Your browser doesn't support javascript.
loading
The effects of supplemental vitamin E on hematological parameters in a rat model of ovarian hormone deficiency.
Pourafshar, Shirin; Johnson, Sarah A; Keshavarz, Behnam; Feresin, Rafaela G; Khalil, Dania A; Chai, Sheau C; Arjmandi, Bahram H.
  • Pourafshar S; Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL.
  • Johnson SA; Center for Advancing Exercise and Nutrition Research on Aging (CAENRA), Florida State University, Tallahassee, FL.
  • Keshavarz B; Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO.
  • Feresin RG; Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL.
  • Khalil DA; Department of Nutrition, Georgia State University, Atlanta, GA.
  • Chai SC; Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL.
  • Arjmandi BH; Department of Behavioral Health and Nutrition, University of Delaware, Newark, DE.
Menopause ; 25(3): 336-342, 2018 03.
Article en En | MEDLINE | ID: mdl-29088013
ABSTRACT

OBJECTIVE:

Menopause is associated with adverse changes in hematological parameters. Although the antioxidative and anti-inflammatory properties of vitamin E have been previously demonstrated, the effects of vitamin E on hematopoietic parameters are not well-documented. This study investigated the effects of supplemental vitamin E on hematological parameters in a rat model of ovarian hormone deficiency.

METHODS:

Twelve-month-old female Sprague-Dawley rats were either sham-operated (Sham) or ovariectomized (Ovx). Animals were randomly divided among five treatment groups (n = 12/group) as follows Sham; Ovx; Ovx + 300, Ovx + 525, or Ovx + 750 mg/kg diet of vitamin E for 100 days.

RESULTS:

Compared with Sham, ovariectomy increased leukocyte subpopulation counts including lymphocytes (2.01 × 10/mm; 95% confidence interval [CI] 0.11, 4.03; P = 0.03), monocytes (0.35 × 10/mm; 95% CI 0.60, 0.11; P = 0.01), neutrophils (0.72 × 10/mm; 95% CI 0.26, 1.19; P = 0.01), eosinophils (0.07 × 10/mm; 95% CI 0.12, 0.30; P = 0.00), and basophils (0.13 × 10/mm; 95% CI 0.04, 0.21; P = 0.02). Medium dose (MD) (-0.26 × 10/mm; 95% CI -0.47, -0.05; P = 0.007) and high dose (HD) (-0.22 × 10/mm; 95% CI -0.43, -0.01; P = 0.037) supplemental vitamin E attenuated Ovx-induced increases in monocyte counts. Low dose (LD) (-0.55 × 10/mm; 95% CI -0.95, -0.15; P = 0.003), MD (-0.61 × 10/mm; P = 0.001), and HD (-0.54 × 10/mm; 95% CI -0.95, -0.14; P = 0.004) supplemental vitamin E attenuated Ovx-induced increases in neutrophil counts. LD (-0.05 × 10/mm; 95% CI -0.08, -0.11; P = 0.006), MD (-0.05 × 10/mm; 95% CI -0.08, -0.11; P = 0.005), and HD (-0.05 × 10/mm; 95% CI -0.09, -0.01; P = 0.004) supplemental vitamin E also attenuated the Ovx-induced increase in eosinophil counts. Only LD (-0.09 × 10/mm; 95% CI -0.17, -0.02; P = 0.009) supplemental vitamin E attenuated the Ovx-induced increase in basophil counts. The remaining hematological parameters assessed were not significantly affected by ovariectomy or supplemental vitamin E.

CONCLUSION:

These findings suggest that vitamin E in the form of α-tocopherol acetate may provide protection against ovarian hormone deficiency-associated adverse changes in hematological parameters.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vitamina E / Insuficiencia Ovárica Primaria / Leucocitos / Antioxidantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vitamina E / Insuficiencia Ovárica Primaria / Leucocitos / Antioxidantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2018 Tipo del documento: Article